Regulator and applications
California State Board of Pharmacy community-pharmacy licensing, ownership disclosures and changes of ownership or location. Representative supporting forms include Ownership Information Form 17A-33 and Seller's Certification 17A-8. Board application materials · ownership-change guidance.
Leadership and personnel
Pharmacist-in-charge (PIC) changes and disassociation notices, employment agreements and the allocation of operational responsibilities. Board PIC guidance.
Commercial terms
Wholesaler and supplier agreements, payer and pharmacy benefit manager (PBM) contracts, software, delivery and specialty-service arrangements. We review payment, audit, termination and transition provisions against the proposed business model.
Facility relationships
Pharmacy services, consultant-pharmacist arrangements, delivery obligations, emergency coverage and responsibility for records and communication.
Ownership and service scope
We assess the pharmacy's license and actual activities separately from the care facility's permissions. The relationship needs clear boundaries between the pharmacy, prescribers and facility personnel. Board pharmacy framework.
Disputed responsibilities
Payment disagreements, service complaints and contract terminations. We examine who agreed to do what and what evidence supports the response.
For the facility side of the relationship, see Long-Term Care & Senior Living.
State licensing
Sterile-compounding applications and ownership or location changes require attention alongside the underlying pharmacy license. We identify the relevant submissions and inspection-response work. Board sterile-compounding applications.
Federal framework
Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act address different compounding models. We assess the business and proposed services before relying on either framework. FDA compounding provisions.
Agreements and procedures
Supplier qualification responsibilities, quality-related contract terms, recalls, complaints and patient-information handling. Legal work should identify obligations without substituting for the pharmacy's technical quality program.
Distinct approvals
A 503B outsourcing facility has a different federal status from a traditional compounding pharmacy. California also has outsourcing and nonresident outsourcing facility licenses. FDA framework · Board outsourcing licenses.
Cross-border operations
We identify California permissions and contracts relevant to services into the state, without assuming a home-state approval answers every question.
Controlled substances
Drug Enforcement Administration (DEA) registration is a separate federal process where implicated by the activity. We identify registration and transition questions alongside state licensing. DEA registration resources.
Yes. Share the proposed structure, current license information and purchase terms. We can identify the transaction and regulatory work before the closing timetable hardens.
Yes. Send the document and any deadline. We will define the scope of the matter and agree on its fixed fee before beginning the work.
